LifeMD, Inc. (LFMD)
USD 5.18
(-8.32%)
USD 5.18
(-8.32%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 152.54 Million | 119.03 Million | 92.87 Million | 37.29 Million | 12.46 Million | 8.32 Million |
| Cost of Revenue | 26.53 Million | 18.66 Million | 17.99 Million | 8.9 Million | 3.27 Million | 1.96 Million |
| Gross Profit | 126.01 Million | 100.36 Million | 74.88 Million | 28.38 Million | 9.19 Million | 6.35 Million |
| Operating Expenses | 148.13 Million | 140.05 Million | 129.18 Million | 86.2 Million | 12.08 Million | 8.41 Million |
| Selling, General and Administrative Expenses | 128.14 Million | 125.33 Million | 122.11 Million | 83.87 Million | 10.56 Million | 8.41 Million |
| Research and Development Expenses | 6.06 Million | 2.97 Million | 778.77 Thousand | 446.74 Thousand | 222.87 Thousand | 120.54 Thousand |
| Other Expenses | 13.92 Million | 11.75 Million | 6.29 Million | 1.88 Million | 1.29 Million | -516.98 Thousand |
| Cost and Expenses | 167.03 Million | 158.71 Million | 147.17 Million | 95.11 Million | 15.35 Million | 10.38 Million |
| Operating Income | -14.48 Million | -39.68 Million | -54.3 Million | -57.81 Million | -2.88 Million | -2.05 Million |
| Interest Expense | 2.59 Million | 1.27 Million | 3.01 Million | 1.66 Million | 761.15 Thousand | 354.38 Thousand |
| Income Tax Expense | 428 Thousand | 360.7 Thousand | 7700.00 | 122.5 Thousand | -122.5 Thousand | -124.7 Thousand |
| Earnings before Tax | -17.41 Million | -44.66 Million | -61.31 Million | -60.4 Million | -3.65 Million | -1.48 Million |
| Net Income | -20.59 Million | -45.02 Million | -61.32 Million | -60.52 Million | -3.52 Million | -1.24 Million |
| Earnings Per Share Basic | -0.70 | -1.45 | -2.27 | -4.24 | -0.36 | -0.14 |
| Earnings Per Share Diluted | -0.70 | -1.45 | -2.27 | -4.24 | -0.36 | -0.14 |
| Weighted Average Shares Outstanding | 33.9 Million | 30.97 Million | 27 Million | 14.27 Million | 9.89 Million | 8.83 Million |
| Weighted Average Shares Outstanding (Diluted) | 33.9 Million | 30.97 Million | 27 Million | 14.27 Million | 9.89 Million | 9.05 Million |
| Gross Margin | 0.83 | 0.84 | 0.81 | 0.76 | 0.74 | 0.76 |
| EBIT Margin | -0.05 | -0.27 | -0.53 | -1.55 | -0.20 | -0.11 |
| Profit Margin | -0.14 | -0.38 | -0.66 | -1.62 | -0.28 | -0.15 |
| EBITDA | -8.21 Million | -39.61 Million | -53.94 Million | -57.48 Million | -2.55 Million | -1.86 Million |
| Earnings Before Tax Margin | -0.09 | -0.33 | -0.58 | -1.55 | -0.23 | -0.25 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 50.66 Million | 44.14 Million | 44.85 Million | 152.54 Million | 38.61 Million | 35.94 Million |
| Cost of Revenue | 7.75 Million | 6.44 Million | 7.41 Million | 26.53 Million | 4.78 Million | 4.54 Million |
| Gross Profit | 42.9 Million | 37.69 Million | 37.44 Million | 126.01 Million | 33.83 Million | 31.39 Million |
| Operating Expenses | 49.2 Million | 43.86 Million | 39.61 Million | 140.5 Million | 38.4 Million | 36.29 Million |
| Selling, General and Administrative Expenses | 44.9 Million | 39.47 Million | 35.96 Million | - | 33.17 Million | 31.68 Million |
| Research and Development Expenses | 2.4 Million | 2.08 Million | 1.99 Million | - | 1.49 Million | 1.38 Million |
| Other Expenses | -1.9 Million | -2.3 Million | -1.65 Million | -6.29 Million | -1.4 Million | -1.1 Million |
| Cost and Expenses | 56.96 Million | 50.31 Million | 47.03 Million | 167.03 Million | 43.18 Million | 40.84 Million |
| Operating Income | -6.3 Million | -6.17 Million | -2.17 Million | -14.48 Million | -4.56 Million | -4.89 Million |
| Interest Expense | 531.46 Thousand | 477.67 Thousand | 622.68 Thousand | 2.59 Million | 713.76 Thousand | 995.67 Thousand |
| Income Tax Expense | 38.6 Thousand | 119.43 Thousand | 428 Thousand | 428 Thousand | -6 Million | -5.38 Million |
| Earnings before Tax | -6.83 Million | -6.64 Million | -2.79 Million | -17.41 Million | -5.28 Million | -5.89 Million |
| Net Income | -6.87 Million | -6.76 Million | -3.73 Million | -20.59 Million | -6.12 Million | -6.73 Million |
| Earnings Per Share Basic | -0.17 | -0.17 | -0.10 | - | -0.18 | -0.21 |
| Earnings Per Share Diluted | -0.17 | -0.17 | -0.10 | - | -0.18 | -0.21 |
| Weighted Average Shares Outstanding | 41.29 Million | 39.24 Million | 36.71 Million | 33.9 Million | 34.47 Million | 32.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 41.29 Million | 39.24 Million | 36.71 Million | 33.9 Million | 34.47 Million | 32.56 Million |
| Gross Margin | 0.85 | 0.85 | 0.83 | 0.83 | 0.88 | 0.87 |
| EBIT Margin | -0.08 | -0.09 | -0.01 | - | -0.07 | -0.09 |
| Profit Margin | -0.14 | -0.15 | -0.08 | -0.14 | -0.16 | -0.19 |
| EBITDA | -4.01 Million | -4.07 Million | -230.81 Thousand | - | -2.83 Million | -3.34 Million |
| Earnings Before Tax Margin | -0.12 | -0.14 | -0.05 | -0.09 | -0.12 | -0.14 |
AROGRANITE
DMTRF
CHNXF
002838
CFIN
CNS